Skip to main content
. Author manuscript; available in PMC: 2019 May 1.
Published in final edited form as: Exp Gerontol. 2018 Feb 3;105:53–69. doi: 10.1016/j.exger.2017.12.026

TABLE 7.

Changes in cognitive and physical function during treatment

Treatment groupa Group differenceb
PLACEBO RAPA
Pre Post P value Difference (95%CI) Pre Post P value Difference (95%CI) P value Difference (95%CI)
Cognitive testsc (n=13) (n=10)
EXIT 6.54 ± 3.73 6.92 ± 4.23 0.71 0.38 [−1.84, 2.61] 7.3 ± 4.92 7.2 ± 4.52 0.95 −0.1 [−3.31, 3.11] 0.78 0.48 [−3.2, 4.17]
SLUMS 24.92 ± 3.23 24.54 ± 3.04 0.62 −0.38 [−2.03, 1.26] 24.3 ± 6.25 23.5 ± 4.7 0.58 −0.8 [−3.92, 2.32] 0.8 0.42 [−2.96, 3.79]
TAPS 26.15 ± 6.99 25.15 ± 5.94 0.34 −1 [−3.18, 1.18] 25.67 ± 7.48 27.2 ± 8.69 0.32 1.44 [−1.68, 4.57] 0.17 −2.44 [−6.02, 1.13]
Physical function (n=14) (n=11)
Grip strength 22.27 ± 7.54 24.07 ± 5.57 0.15 1.79 [−0.75, 4.33] 24.33 ± 8.2 25.63 ± 6.65 0.4 1.3 [−1.98, 4.59] 0.8 0.49 [−3.44, 4.41]
Walking speed 7.72 ± 1.6 7.17 ± 1.12 0.047 −0.55 [−1.09, −0.01] 8.8 ± 3.64 7.75 ± 1.12 0.34 −1.04 [−3.38, 1.3] 0.66 0.49 [−1.88, 2.86]
a

. To compare changes over the treatment period, the “Pre” values (taken before treatment was initiated) were subtracted from the “Post” values to obtain the “Difference” within a treatment group and were assessed by paired t-tests to identify any statistically significant changes in either the RAPA or Placebo groups. The p-values are shown. The direction of the change is indicated in the “Difference column” where a positive number indicates a higher mean value after treatment and a negative value reflects a lower value after treatment. The 95% confidence interval is shown in brackets.

b

. To determine whether there was a difference in the RAPA vs. the placebo group, the mean “difference” values were compared using a Welch’s t-test. The resulting p-values are shown. The difference mean changes seen in the RAPA and placebo groups are shown with the 95% confidence interval in brackets.

c

. The “post” values are taken from the 16 week time point for phase 1 and from the 6–8 week timepoint for phase 2. Cognitive tests were done only twice on each subject to avoid complications due to learning.